Recently Cuban researchers from University of Habana registered
CimaVax EGF a new vaccine for lung cancer patients. FDa has introduced it in some trials, but the approval will be after 3-5 years. In the meantime Canada, Peru and Brazil are interested in having this product apprived. As USA has more than 1.5 million lung cancer sufferers, we will se in short time a new medical tourism targeting Peru and Brazil. Not because it is the cheaper way but only way to get this treatment.